Avezone-T 250mg/31.25mg Injection
Marketer
Jasco Labs Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Avezone-T 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly under medical guidance; adhere to the prescribed schedule and complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, and pregnant or lactating individuals should consult their doctor before use. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Avezone-T 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Avezone-T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Avezone-T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Avezone-T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Avezone-T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Avezone-T 250mg/31.25mg Injection works:
The injectable formulation, Avezone-T 250mg/31.25mg, unites the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Tazobactum counteracts bacterial resistance, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Avezone-T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Avezone-T 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Avezone-T 250mg/31.25mg Injection necessitates prudence during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The injection Avezone-T 250mg/31.25mg can cause drowsiness, visual disturbances, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Avezone-T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Caution is advised when administering Avezone-T 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Dosage alteration for Avezone-T 250mg/31.25mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Avezone-T 250mg/31.25mg Injection :
Omit a scheduled dose of Avezone-T 250mg/31.25mg Injection? Seek medical advice immediately.
Facts to Know About Avezone-T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently